BRAIN will provide Genencor access to these technologies and especially to its vast metagenome resources of some 150 million genes of yet uncultured microorganisms. Enzymes and biosynthetic pathways of interest will then be genetically engineered in microbial production strains for the production of important biochemicals. The products can replace petrochemicals and be used in e.g. biofuels, plastics, rubber, adhesives and cosmetics.
